Renuka Iyer MD
Renuka Iyer
MD
Professor
Jacobs School of Medicine & Biomedical Sciences
Specialty/Research Focus
Internal Medicine; Medical Oncology; Oncology
Education and Training:
- Fellowship, Medical Oncology, Roswell Park Cancer Institute (2004)
- Residency, Internal Medicine, Cornell University School of Medicine (2001)
- Internal Medicine, Fox Chase Center (1998)
- Internal Medicine, University of Bombay (1995)
Employment:
- Professor, Medicine, Roswell Park Comprehensive Cancer Center Jacobs School of Medicine & Biomedical Sciences (2017-present)
- Associate Professor of Medicine, Oncology, University at Buffalo Jacobs School of Medicine & Biomedical Sciences (2012-present)
- Associate Professor of Oncology, Medicine, Roswell Park Cancer Institute Jacobs School of Medicine & Biomedical Sciences (2011-present)
- Assistant Professor of Medicine, Medicine, University at Buffalo Jacobs School of Medicine & Biomedical Sciences (2004–2012)
- Assistant Professor of Oncology, Medicine, Roswell Park Cancer Institute Jacobs School of Medicine & Biomedical Sciences (2044–2011)
Awards and Honors:
- DELPHI Neuroendocrine Tumor Panelist (2011)
- Invited R01 Grant Application Reviewer, NIAID/NIH/DHHS (2010)
- American Cancer Society Mentored Research Scholar Award (2008)
- Best Teacher Award, Roswell Park Oncology Fellows (2008)
- Thomas Frawley Resient Research Fellowship, UB (2003)
- Junior Investigator Award, Conference on Chemical Modifiers in Cancer Treat (1997)
- Distinction in Pharmacology, University of Bombay (1990)
Grants and Sponsored Research:
- January 2008–December 2012
Targeted Therapies in Hepatocellular Cancer.
ACS
Role: Principal Investigator - April 2007–December 2009
Pre-clinical Evaluation of the Efficacy and Anti-angiogenic Effects of Sunitinib on Hepatocellular Carcinoma (HCC) in the Woodchuck Model of Hepatitis B related HCC.
Roswell Park Alliance Foundation
Role: Principal Investigator - July 2005–June 2009
Open Label Study of Capecitabine, Gemcitabine and Bevacizumab in Pancreatic Cancer: A Phase II Study with Biologic Correlates
NCCN
Role: Principal Investigator - July 2005
Capecitabine in Combination with Oxaliplatin and Radiation: A Phase II Neoadjuvant Study for Esophageal Cancer
NCCN
Role: Co-Investigator
Journal Articles:
- Samuel S, Mukherjee S, Ammannagari N, Pokuri VK, Kuvshinoff B, Groman A, LeVea CM, Iyer R. (2018) Clinicopathological characteristics and outcomes of rare histologic subtypes of gallbladder cancer over two decades: A population-based study. PLoS One (Jun), 13(6): 0198809-0198809.
- Gabriel E, Gandhi S, Attwood K, Kuvshinoff B, Hochwald S, Iyer R. (2017) Gemcitabine and capecitabine for advanced biliary cancer. J Gastrointest Oncol (Aug), 8(4): 728-736.
- Singla S, LeVea CM, Pokuri VK, Attwood KM, Wach MM, Tomaszewski GM, Kuvshinoff B, Iyer R. (2016) Ki67 score as a potential predictor in the selection of liver-directed therapies for metastatic neuroendocrine tumors: a single institutional experience. J Gastrointest Oncol (Jun), 7(3): 441-448.
- Oyasiji T, Zhang J, Kuvshinoff B, Iyer R, Hochwald SN. (2015) Molecular Targets in Biliary Carcinogenesis and Implications for Therapy. Oncologist (Jul), 20(7): 742-751.
- Al Ustwani O, Lohr J, Dy G, Levea C, Connolly G, Arora P, Iyer R. (2014) Eculizumab Therapy for Gemcitabine Induced Hemolytic Uremic Syndrome: Case Series and Concise Review. J Gastrointest Oncol (Feb), 5(1): 30-33.
- Yang GY, Malik NK, Chandrasekhar R, Ma WW, Flaherty L, Iyer R, Kuvshinoff B, Gibbs J, Wilding G, Warren G, May KS, Ma W. (2013) Change in CA 19-9 levels after chemoradiotherapy predicts survival in patients with locally advanced unresectable pancreatic cancer. J Gastrointest Oncol (Dec), 4(4): 361-369.
- Malik NK, May KS, Chandrasekhar R, Wee W, Flaherty L, Iyer R, Gibbs J, Kuvshinoff B, Wilding G, Warren G, Yang GY. (2012) Treatment of locally advanced unresectable pancreatic cancer: a 10-year experience. J Gastrointest Oncol (Dec), 3(4): 326-334.
- Al Ustwani O, Iancu D, Yacoub R, Iyer R. (2012) Detection of Circulating Tumor Cells in Cancers of Biliary Origin. J Gastrointest Oncol (Jun), 3(2): 97-104.
- McLaughlin HM, Sakaguchi R, Liu C, Igarashi T, Pehlivan D, Chu K, Iyer R, Cruz P, Cherukuri PF, Hansen NF, Mullikin JC, Biesecker LG, Wilson TE, Ionasescu V, Nicholson G, Searby C, Talbot K, Vance JM, Züchner S, Szigeti K, Lupski JR, Hou YM, Green ED, Antonellis A. (2010) Compound heterozygosity for loss-of-function lysyl-tRNA synthetase mutations in a patient with peripheral neuropathy. Am J Hum Genet (Oct), 87(4): 560-566.
- Mahajan P, Weber-Shrikant E, Iyer R, Sitrin M, Lohr J, Arora P. (2010) CKD in a patient with pancreatic carcinoma. Am J Kidney Dis (Sep), 56(3): 591-594.
- Mahajan P., Weber-Shrikant E,, Iyer R, Sitrin MD, Lohr JW, Arora P. (2010) CKD in a Patient with Pancreatic Cancer. Am J Kidney Diseases (Jan), 56: 591-594.
- Bharthuar A, Pearce L, Litwin A, LeVea C, Kuvshinoff B, Iyer R. (2009) Metastatic pancreatic adenocarcinoma and renal cell carcinoma treated with gemcitabine and sunitinib malate. A case report. JOP (Sep), 10(5): 523-527.
- Javle M, Yu J, Garrett C, Pande A, Kuvshinoff B, Litwin A, Phelan J, Gibbs J, Iyer R. (2009) Bevacizumab combined with gemcitabine and capecitabine for advanced pancreatic cancer: a phase II study. Br J Cancer (Jun), 100(12): 1842-1845.
- Foster JM, Hoshi H, Gibbs JF, Iyer R, Javle M, Chu Q, Kuvshinoff B. (2007) Gallbladder cancer: Defining the indications for primary radical resection and radical re-resection. Ann Surg Oncol (Feb), 14(2): 833-840.
- Bhagat V, Javle M, Yu J, Agrawal A, Gibbs JF, Kuvshinoff B, Nava E, Iyer R. (2006) Combined hepatocholangiocarcinoma: case-series and review of literature. Int J Gastrointest Cancer (Jan), 37(1): 27-34.
- Chadha MK, LeVea C, Javle M, Kuvshinoff B, Vijaykumar R, Iyer R. (2004) Anaplastic pancreatic carcinoma. A case report and review of literature . JOP (Nov), 5(6): 512-515.
Professional Memberships:
- American Association for the Study of Liver Diseases (2010–present)
- Carcinoid.org NET Physician/Expert (2010–present)
- American College of Gastroenterology (2009–present)
- American College of Surgeons Oncology Group (2004–present)
- American Association for Cancer Research (2004–present)
- American Society of Clinical Oncology (2001–present)
- Radiation Research Society, Student Member (1998–2001)
- Maharashtra Medical Council, India (1989–present)